Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy

We sought to quantify contribution of radiomics and SUVmax at PET/CT to predict clinical outcome in lung cancer patients treated with stereotactic body radiotherapy (SBRT). 150 patients with 172 lung cancers, who underwent SBRT were retrospectively included. Radiomics were applied on PET/CT. Princip...

Descripción completa

Detalles Bibliográficos
Autores principales: Oikonomou, Anastasia, Khalvati, Farzad, Tyrrell, Pascal N., Haider, Masoom A., Tarique, Usman, Jimenez-Juan, Laura, Tjong, Michael C., Poon, Ian, Eilaghi, Armin, Ehrlich, Lisa, Cheung, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838232/
https://www.ncbi.nlm.nih.gov/pubmed/29507399
http://dx.doi.org/10.1038/s41598-018-22357-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838232/
https://www.ncbi.nlm.nih.gov/pubmed/29507399
http://dx.doi.org/10.1038/s41598-018-22357-y

Ejemplares similares